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Abstract
Background: The impact of bronchiectasis on sedentary behaviour and physical activity is unknown. It is important
to explore this to identify the need for physical activity interventions and how to tailor interventions to this patient
population. We aimed to explore the patterns and correlates of sedentary behaviour and physical activity in
bronchiectasis.
Methods: Physical activity was assessed in 63 patients with bronchiectasis using an ActiGraph GT3X+ accelerometer
over seven days. Patients completed: questionnaires on health-related quality-of-life and attitudes to physical activity
(questions based on an adaption of the transtheoretical model (TTM) of behaviour change); spirometry; and the
modified shuttle test (MST). Multiple linear regression analysis using forward selection based on likelihood ratio
statistics explored the correlates of sedentary behaviour and physical activity dimensions. Between-group analysis
using independent sample t-tests were used to explore differences for selected variables.
Results: Fifty-five patients had complete datasets. Average daily time, mean(standard deviation) spent in sedentary
behaviour was 634(77)mins, light-lifestyle physical activity was 207(63)mins and moderate-vigorous physical activity
(MVPA) was 25(20)mins. Only 11% of patients met recommended guidelines. Forced expiratory volume in one-second
percentage predicted (FEV1% predicted) and disease severity were not correlates of sedentary behaviour or physical
activity. For sedentary behaviour, decisional balance ‘pros’ score was the only correlate. Performance on the MST was
the strongest correlate of physical activity. In addition to the MST, there were other important correlate variables for
MVPA accumulated in ≥10-minute bouts (QOL-B Social Functioning) and for activity energy expenditure (Body Mass
Index and QOL-B Respiratory Symptoms).
Conclusions: Patients with bronchiectasis demonstrated a largely inactive lifestyle and few met the recommended
physical activity guidelines. Exercise capacity was the strongest correlate of physical activity, and dimensions of the
QOL-B were also important. FEV1% predicted and disease severity were not correlates of sedentary behaviour or
physical activity. The inclusion of a range of physical activity dimensions could facilitate in-depth exploration of
patterns of physical activity. This study demonstrates the need for interventions targeted at reducing sedentary
behaviour and increasing physical activity, and provides information to tailor interventions to the bronchiectasis
population.
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Background
There is strong evidence that adherence to physical ac-
tivity guidelines is associated with health benefits and
reduced mortality in both healthy and chronic disease
populations [1,2]. There is no specific evidence that
physical activity is beneficial in bronchiectasis; however
it is strongly related to mortality and lung health in
other respiratory conditions such as chronic obstructive
pulmonary disease (COPD) and cystic fibrosis [3-5].
Promoting physical activity has been proposed as a key
component of care in chronic respiratory disease
[2,3,6,7]. International recommendations for the whole
population promote a minimum of 150 minutes of at
least moderate physical activity per week (accumulated
in at least 10-minute bouts) and a restriction on ex-
tended periods of sedentary behaviour for promoting
and maintaining health [1]. The impact of bronchiec-
tasis on sedentary behaviour and physical activity is
unknown. It is important to explore this to identify the
need for physical activity interventions and how to
tailor interventions to this patient population.
Objective assessment of sedentary behaviour and
physical activity using activity monitors has been rec-
ommended in preference to questionnaires [7-9]. In this
study, we chose to use the ActiGraph activity monitor
as it is one of the most studied activity monitors with
demonstrated reliability and validity in respiratory disease
populations [10,11]. The ActiGraph activity monitor mea-
sures many different physical activity dimensions but cur-
rently there is limited research to inform clinicians on
which of these variables are most useful. Van Remoortel
and colleagues have proposed that time spent in different
physical activity intensities, energy expenditure and step
counts should all be considered to provide a comprehen-
sive assessment [12]. The ActiGraph activity monitor also
measures time spent in sedentary behaviours such as lying
and sitting. Previous research has highlighted how seden-
tary behaviour has an important role on patients’ clinical
progression [13].
A range of clinical characteristics (disease severity, ex-
ercise capacity, health-related quality-of-life (HRQoL)
and symptoms) have been shown to impact on sedentary
behaviour and physical activity in other respiratory con-
ditions [13-16]. However, their impact in bronchiectasis
is unknown.
Additionally psychological and behavioural factors may
also have an impact on sedentary behaviour and physical
activity. An adaption of the transtheoretical model (TTM)
of behaviour change can be used as a framework to iden-
tify why patients with bronchiectasis engage in physical
activity or not, and when and how individuals are likely
to change their physical activity behaviour [17,18]. The
TTM constructs include the stages of change, self-efficacy,
decisional balance and both cognitive and behavioural
processes of change (more details included in Table 1 and
Additional file 1). The TTM assumes that behaviour
change is a dynamic process rather than an all-or-nothing
phenomenon [19]. However, specific data in patients with
bronchiectasis using the TTM is not yet available [18].
Understanding the links between physical activity and sed-
entary behaviour, and clinical and psychological character-
istics will potentially inform the development of future
physical activity interventions.
The overall aim of this research was to explore seden-
tary behaviour and physical activity and correlates of
these behaviours in patients with bronchiectasis. Specific
objectives of this research were to explore patterns of
physical activity in patients with bronchiectasis and de-
termine if patients meet the current physical activity
guidelines; and to examine the relationship between
physical activity levels of patients with bronchiectasis
and clinical characteristics (disease severity, exercise capacity,
HRQoL and other symptoms of their disease) and constructs
of the TTM (stages of change, self-efficacy, decisional bal-
ance and processes of change).
The research hypothesis was that patients with bron-
chiectasis would have high levels of sedentary behaviour
and low levels of physical activity and these would be re-
lated to clinical characteristics and constructs of the
TTM. More specifically, it was hypothesised that lower
sedentary behaviour and higher levels of physical activity
would be related to greater exercise capacity, greater
lung function, better HRQoL and higher self-efficacy,
perceiving more benefits of physical activity and using
more processes of change.
Methods
Participant selection
Due to the exploratory nature of the study, a sample of
63 patients was feasible based on constraints of time
(one-year time period) and availability of patients. Con-
secutive patients attending respiratory clinics at the
three selected hospital sites were screened for eligibility.
Inclusion criteria were: aged ≥18 years, diagnosis of
bronchiectasis confirmed by high-resolution CT/CT, ≤10
pack-year smoking history, clinically stable (no pulmon-
ary exacerbation [more details in Additional file 1] and
no significant change in symptoms or medication in the
last four weeks) and sputum bacteriology completed
over the past three months. Exclusion criteria were:
current severe haemoptysis, pregnancy or any other con-
comitant condition that would prevent participation.
Study recruitment occurred over 12 months and patients
were recruited across all seasons. The study was approved
by Northern Ireland Research Ethics Committees (Ethics
Approval Reference: 12/NI/0044) and research departments
of all participating hospitals. Written informed consent
was obtained from all study patients.
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Study design
This was a cross-sectional study using quantitative
methodology (Figure 1). Patients attended Visit 1 where
age and gender were recorded and an assessment of
body mass index (BMI) and spirometry was conducted.
The ActiGraph was attached and worn for seven con-
secutive days following Visit 1. Eight days later, patients
attended Visit 2 where they returned the ActiGraph and
activity log and completed study questionnaires, spirom-
etry, a blood test for C-reactive protein, and the Modified
Shuttle Test (MST) [20].
Clinical measurements
Height and weight were measured in light clothing and
without shoes using SECA digital scales and stadiometer.
Spirometry was assessed using MicroLab spirometer
ML3500 and classified according to American Thoracic
Society/European Respiratory Society Guidelines [21].
Disease severity was calculated using the Bronchiectasis
Severity Index (BSI) to identify patients at risk of
exacerbations, hospitalisations and mortality [22] (see
Additional file 1).
Physical activity was measured using the ActiGraph
GT3X+ accelerometer (ActiGraph, Pensacola, Florida).
Patients wore the ActiGraph during all waking hours for
seven consecutive days following Visit 1. The ActiGraph
was worn on an elastic belt and patients were instructed
to position the ActiGraph on the anterior axillary line of
the hip on their dominant side. They were advised to
remove the ActiGraph before sleeping and prior to
water-based activities. Patients recorded any non-wear
periods in a daily activity log. The ActiGraph was initia-
lised using the manufacturer’s software (ActiLife version
6.8.0) to record movement in counts per minute summed
over 15-second epochs. On Visit 1, patients were offered
daily, alternate-day or once-weekly reminders to wear the
ActiGraph. Each patient’s ActiGraph data was considered
valid if there were ≥10 hours of wear-time per day for ≥5
days, to include a Saturday or Sunday [23,24]. Using
ActiLife software, wear-time validation was applied
Table 1 Description of each component of the transtheoretical model (TTM)
TTM construct [18] Description [18]
Stage of change
Pre-contemplation No intention to engage in regular physical activity
Contemplation Intend to engage in regular physical activity in next 6 months
Preparation Immediate intentions and commitment to engage in regular physical activity
Action Initiated engagement in regular physical activity in last 6 months
Maintenance Maintained engagement of regular physical activity for longer than 6 months
Self-efficacy Personal confidence towards physical activity commitment when: Tired/In a bad
mood/Do not have time/On vacation/It is raining or snowing/Having
respiratory symptoms*
Decisional balance
Pros Perceived benefits of engaging in regular physical activity
Cons Perceived barriers to engaging in regular physical activity
Cognitive processes of change
Increasing knowledge Finding information on the benefits of physical activity and the current recommendations
for physical activity
Being aware of risk Concern for the risks of being physically inactive
Caring about consequences Realising social and environmental benefits that physical activity has
Comprehending benefits Assessing physical activity status and the values related to physical activity
Increasing healthy opportunities Awareness, availability and acceptance by the individual of physical activity in the society
Behavioural processes of change
Substituting alternatives Substituting inactive options for active options
Enlisting social support Seeking out social support to increase and maintain physical activity
Rewarding oneself Providing rewards for being more active
Committing oneself Setting goals and making commitments for physical activity
Reminding oneself Controlling factors that have a negative effect on physical activity to prevent relapse and
using stimuli to increase physical activity level
*Question on ‘having respiratory symptoms’ was added to the original five questions.
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using established parameters which allowed for a 2-
minute interval of non-zero counts with an up/down-
stream 30 minutes of consecutive zero counts window
[25]. Patient-completed activity logs were cross-checked
to explore non-wear periods. Details of sedentary be-
haviour and physical activity dimensions are included
in Additional file 1.
Study questionnaires were administered and completed
during Visit 2. The questionnaires included: Quality of
Life Questionnaire-Bronchiectasis (QOL-B) [26], Leicester
Cough Questionnaire (LCQ) [27], Stages of Change
Questionnaire [28], Marcus’s Self-Efficacy Questionnaire
(with additional disease-specific question) [29], Marcus’s
Decisional Balance Questionnaire [30] and Marcus’s
Processes of Change Questionnaire [31]. Questionnaires
were completed in a standardised order and were cross-
checked by researchers to ensure no missing data (see
Additional file 1).
Exercise capacity was measured using the MST, a pro-
gressive 15-stage exercise field test which is based on a
standardised protocol [20]. The MST was performed
twice with ≥20 minute rest between tests. The greatest
distance completed in either MST was used for analysis.
The MST has been shown to have good reliability and
validity [32].
Statistical analysis
Descriptive statistics were used to summarise demographic and
clinical characteristics and physical activity intensity categories.
Multiple linear regression analysis using forward selec-
tion based on likelihood ratio statistics was completed
with sedentary behaviour and physical activity dimen-
sions as the dependent variables. Dependent variables
included daily sedentary behaviour time and different
physical activity dimensions (see Additional file 1). Inde-
pendent variables entered into the model included: BSI
score, age, gender, BMI, FEV1% predicted, MST, LCQ
domains, QOL-B domains except QOL-B Treatment
Burden (this response is not scored for every patient)
and constructs of the TTM (Marcus’s Self-Efficacy average
score, Marcus’s Decisional Balance ‘pros’ and ‘cons’ scores,
Marcus’s Processes of Change cognitive and behavioural
average scores). As this was an exploratory study, no cor-
rection was made for multiplicity. The significance levels
are therefore descriptive rather than inferential.
Between-group analysis using independent sample
t-tests were used to explore differences for selected
variables. All statistical analyses were performed using
SPSS version 20.0.0 (IBM). Unless otherwise stated, sum-
mary data are reported as mean(SD) and statistical signifi-
cance as p < 0.05.
Figure 1 Study flow diagram showing patient enrolment, allocation and analysis. Abbreviations: QOL-B - Quality of Life Questionnaire-Bronchiectasis;
LCQ - Leicester Cough Questionnaire; Transtheoretical model (TTM) questionnaires - Marcus’s Self-Efficacy Questionnaire, Marcus’s Decisional Balance
Questionnaire, Marcus’s Processes of Change Questionnaire; MST - Modified Shuttle Test.
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Results
Sixty-three patients completed the study visits. Eight
datasets were not valid, leaving fifty-five datasets for
analysis (Figure 1 and Table 2). BSI scores categorised
patients’ disease severity as mild (49%), moderate (33%)
and severe (18%) [9]. In general, bronchiectasis impacted
on patients’ HRQoL across most QOL-B domains. The
QOL-B indicated that patients perceived a high Treat-
ment Burden and a low Health Perception. They had
good Emotional Functioning and were not largely af-
fected by Respiratory Symptoms. The LCQ indicated
that chronic cough impacted on HRQoL, with highest
perceived impact on the Physical domain (lowest LCQ
domain score). C-reactive protein at study entry was
4(4)mg/L (Table 2).
Sedentary behaviour and physical activity levels
Average daily time spent in sedentary behaviour was
634(77)mins, light-lifestyle physical activity was 207(63)mins
and moderate-vigorous physical activity (MVPA) was
25(20)mins. Only 11% of patients met the recommended
physical activity guidelines of ≥150mins of at least moder-
ate physical activity per week [1]. Patients completed
6001(2780) daily steps and 232(75)mins of daily total
physical activity. Using the graduated step-based physical
activity index, 42% of patients were classified as inactive,
29% as low active and 29% as somewhat active and
above [33]. Mean distance covered in the MST was
511(273)metres (Table 3).
Correlates of sedentary behaviour and physical activity
Table 4 shows variables for inclusion in the regression
analysis with a p-value below 5%. The correlates selected
Table 2 Demographic and clinical characteristics of
patients with bronchiectasis (n = 55)
Age (years) 63 (10)
Gender (male / female) 22 [40]/33 [60]
BMI (kg/m2) 27 (4)
FEV1 (litres) 2 (1)
FEV1 (% predicted) 76 (21)
FVC (litres) 3 (1)
FVC (% predicted) 94 (19)
FEF% 38 (22)
FEF25–75 (litres) 1 (0.8)
C-Reactive Protein (mg/L) 4 (4)
Disease severity (%)*
Mild 27 [49]
Moderate 18 [33]
Severe 10 [18]
Smoking history
Never (%) 46 [84]
Ex-smoker (%) 9 [16]
Antibiotic courses
Number of oral antibiotic courses within last year 3 (2)
Number of IV antibiotic courses within last year 0-3 (range)
QOL-B (0–100, 0 worst to 100 best)
Physical Functioning 59 (31)
Role Functioning 56 (12)
Vitality 63 (13)
Emotional Functioning 83 (17)
Social Functioning 60 (23)
Treatment Burden (n = 41) 39 (13)
Health Perception 45 (16)
Respiratory Symptoms 70 (19)
LCQ (1–7, 1 worst to 7 best)
Physical 4.96 (1.43)
Psychological 5.27 (1.52)
Social 5.50 (1.29)
LCQ total score (range from 3 to 21) 15.72 (3.99)
Results are Mean (SD) or Frequency [%].
Abbreviations: BMI Body Mass Index, FEF Forced Expiratory Flow, FEF25–75 Forced
Expiratory Flow between 25% to 75%, FEV1% predicted Forced Expiratory
Volume in one-second percentage predicted, FVC Forced Vital Capacity
(% predicted), LCQ Leicester Cough Questionnaire, QOL-B Quality of Life in
Bronchiectasis.
*Disease severity based on Bronchiectasis Severity Index [22].
Table 3 Sedentary behaviour (ActiGraph), physical
activity (ActiGraph) and exercise capacity (MST) for
patients with bronchiectasis (n = 55)
Average times in sedentary behaviour and different
physical activity intensities:
Sedentary behaviour time (mins/day) 634 (77)
Light-lifestyle physical activity time (mins/day) 207 (63)
Total MVPA time (mins/day) 25 (20)
MVPA10+ time (mins/week) 44 (64)
MVPA10+ time (mins/day) 6 (9)
Activity energy expenditure (kcals/day) 309 (183)
Daily step counts 6001 (2780)
Total physical activity (mins/day) 232 (75)
Physical activity category Inactive [%] 23 [42]
Physical activity category Low active [%] 16 [29]
Physical activity category Somewhat active and above [%] 16 [29]
Exercise capacity:
MST (metres) 511 (273)
Results are Mean (SD) or Frequency [%].
ActiGraph physical activity categories: Inactive (<5000 steps per day), low active
(5000–7499 steps per day) and somewhat active and above (≥7500 steps per day).
Abbreviations: kcals/day kilocalories per day, MVPA moderate-vigorous physical
activity, MVPA10+ MVPA accumulated in ≥10-minute bouts, mins/day minutes
per day, mins/week minutes per week, MST Modified Shuttle Test.
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in this study explained 10-38% of the variance in seden-
tary behaviour and physical activity. Forced expiratory
volume in one-second percentage predicted (FEV1% pre-
dicted) and disease severity (BSI score) were not corre-
lates of sedentary behaviour or any physical activity
variable. The MST was not a correlate of sedentary be-
haviour time. For sedentary behaviour time, decisional
balance ‘pros’ score was a correlate variable; with those
who were more sedentary observing less benefits of
physical activity. For physical activity variables, the MST
was the most strongly related correlate variable. For
MVPA accumulated in ≥10-minute bouts, QOL-B Social
Functioning was also a correlate variable; with those
who completed more MVPA in ≥10-minute bouts having
higher Social Functioning. For activity energy expenditure,
BMI and QOL-B Respiratory Symptoms were also correl-
ate variables; with those who had greater activity energy
expenditure having a higher BMI and worse Respiratory
Symptoms (Table 4).
Patients with moderate/severe disease (BSI score: ≥5)
spent significantly less time in daily total MVPA time,
had lower activity energy expenditure, fewer daily step
counts and achieved lower MST distance than those
with mild disease (BSI score: ≤4) (Table 5).
Fifty-five percent of patients reported that they were
in an ‘inactive’ stage of change (pre-contemplation, con-
templation or preparation stages) while 45% reported
themselves to be in an ‘active’ stage of change (action or
maintenance stages) in relation to their participation in
physical activity (Table 6). Patients reported reduced
confidence when faced with situations that could impact
on their ability to participate in physical activity; being
most confident that they could be physically active when
on holiday and least confident when they had respiratory
Table 4 Correlate variables for sedentary behaviour and physical activity for patients with bronchiectasis (n = 55)
Dependent variable Correlate variable Unstandardised coefficients B(SE) R2 adjusted p value
Daily sedentary behaviour time Marcus’s Decisional Balance ‘pros’ score −28.964 (10.609) 0.107 0.009
Daily light-lifestyle PA time No correlates — — —
Daily total MVPA time MST 0.037 (0.008) 0.258 0.001
Daily MVPA10+ time QOL-B Social Functioning 0.162 (0.050) 0.149 0.002
MST 0.009 (0.004) 0.207 0.032
Daily AEE MST 0.351 (0.077) 0.269 0.001
BMI 12.769 (4.767) 0.345 0.010
QOL-B Respiratory Symptoms −2.215 (1.074) 0.384 0.044
Daily step counts MST 5.813 (1.127) 0.322 0.001
Daily total PA time MST 0.088 (0.035) 0.087 0.016
Abbreviations: AEE activity energy expenditure, BMI Body Mass Index, MST Modified Shuttle Test, MVPA moderate-vigorous physical activity, MVPA10+ MVPA
accumulated in ≥10-minute bouts, PA physical activity, QOL-B Quality of Life-Bronchiectasis.
Table 5 Differences across disease severity for sedentary behavior, physical activity and exercise capacity for patients
with bronchiectasis
Disease severity: Mild BSI
score ≤ 4(n = 27)
Disease severity: Moderate/severe
BSI score ≥ 5(n = 28)
Sedentary behavior time (mins/day) 632 (64) 635 (88)
Light-lifestyle physical activity time (mins/day) 210 (55) 204 (71)
Total MVPA time (mins/day) 32 (19) 18 (18)a
MVPA10+ time (mins/day) 8 (10) 5 (8)
Activity energy expenditure (kcals/day) 390 (173) 231 (159)b
Daily step counts 6898 (2783) 5137 (2532)c
Total physical activity time (mins/day) 242 (65) 221 (84)
MST (metres) 593 (323) 432 (199)d
Results are Mean (SD).
Note: Disease severity expressed as Bronchiectasis Severity Index score [22].
Abbreviations: kcals/day kilocalories per day, MVPA moderate-vigorous physical activity, MVPA10+ MVPA accumulated in bouts ≥10 minutes, mins/day minutes per day,
MST Modified Shuttle Test.
aDaily Total MVPA: significant difference between groups (p = 0.005).
bDaily Activity Energy Expenditure: significant difference between groups (p = 0.001).
cDaily Step Counts: significant difference between groups (p = 0.017).
dMST: significant difference between groups (p = 0.030).
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symptoms. They also perceived both benefits (‘pros’) and
barriers (‘cons’) to physical activity. Decisional balance
scores (perceived benefits minus perceived barriers)
showed patients perceived marginally more benefits.
Overall, patients used cognitive and behavioural strat-
egies equally in their physical activity behaviour
(Table 6).
Discussion
This is the first study to report patterns of sedentary
behaviour and physical activity in bronchiectasis. The
results demonstrate a more sedentary and less active
profile for people with bronchiectasis compared to the
recommended guidelines for physical activity. These
findings are important as recent research has suggested
a link with inactivity and decreased survival, poorer
HRQoL and increased healthcare utilisation in chronic
disease populations such as COPD and diabetes
[3,4,33-36]. Furthermore, there is increasing evidence
that a high level of sedentary behaviour is associated
with adverse health outcomes in chronic disease popu-
lations [36-38].
To contextualise these study findings, we have com-
pared our bronchiectasis data to similar ActiGraph data
available for English, Swedish and USA healthy popula-
tions [39-43] and to another respiratory population [16]
(see Additional file 2). Albeit the healthy data sets are
more heterogeneous in terms of age and ethnicity, some
important contrasts emerge. Patients with bronchiectasis
appear to have similar levels of sedentary behaviour and
physical activity compared to the English healthy popula-
tion [42]; both populations fall well below recommended
guidelines for physical activity [1]. Patients with bronchi-
ectasis appear to be more sedentary and less physically ac-
tive compared to healthy Swedish and USA populations
[39-41,43]. USA population-based ActiGraph data is avail-
able in COPD. Patients with bronchiectasis appear to have
a similar sedentary behaviour and physical activity profile;
despite being younger in age [16]. When designing phys-
ical activity interventions in bronchiectasis, researchers
may need to consider the impact of patients’ baseline sed-
entary behaviour and physical activity levels as well as
current and new symptoms.
We hypothesised that lower levels of sedentary behav-
iour and higher levels of physical activity would be related
to greater exercise capacity, greater lung function, better
HRQoL and higher self-efficacy, perceiving more benefits
of physical activity and using more processes of change.
FEV1% predicted and BSI score did not correlate with sed-
entary behaviour time or physical activity variables
highlighting that neither of these assessments should be
used clinically as indicators of either sedentary behaviour
or physical activity. Whilst MST did not predict seden-
tary behavior, MST consistently correlated with physical
Table 6 Stages of change scores and TTM questionnaire
scores for patients with bronchiectasis
Stage of change:
Stage 1 pre-contemplation [%] 4 [7]
Stage 2 contemplation [%] 6 [11]
Stage 3 preparation [%] 20 [36]
Stage 4 action [%] 3 [6]
Stage 5 maintenance [%] 22 [40]
Marcus’s self-efficacy:
(1–5, 1 not at all confident to 5 very
confident in being active)
When tired 2.27 (0.95)
When in a bad mood 2.96 (1.19)
When do not have time 2.53 (1.07)
When on vacation 3.35 (1.22)
When raining/snowing 2.33 (1.25)
When having respiratory symptoms 1.65 (0.97)
Mean of all 6 self-efficacy domains 2.52 (0.48)
Marcus’s decisional balance:
(scores > 0 indicate perceptions of
more benefits than barriers in being
active, scores < 0 indicate perceptions
of more barriers than benefits in
being active)
Pros (1–5, higher scores perceive more
benefits in being active)
3.53 (0.93)
Cons (1–5, higher scores perceive more
barriers in being active)
2.62 (0.75)
Overall decisional balance score (difference
between pros minus cons)
0.91 (1.01)
Marcus’s processes of change:
(1–5, higher scores indicate greater usage
of strategies to become more active)
Cognitive Processes
Increasing knowledge 2.49 (0.81)
Being aware of risks 2.35 (1.01)
Caring about consequences to others 2.52 (1.04)
Comprehending benefits 3.16 (1.01)
Increasing healthy opportunities 2.34 (0.94)
Cognitive processes mean 2.57 (0.78)
Behavioural Processes
Substituting alternatives 2.99 (0.98)
Enlisting social support 2.40 (0.93)
Rewarding oneself 2.44 (0.94)
Committing oneself 3.07 (0.95)
Reminding oneself 1.92 (0.72)
Behavioural processes mean 2.56 (0.70)
Results are Mean (SD) or Frequency [%].
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activity variables. This association between physical
activity and exercise capacity has previously been dem-
onstrated in bronchiectasis [44] and highlights the
potential importance of exercise interventions, such as
pulmonary rehabilitation, to improve physical activity
levels in patients with bronchiectasis. Based on positive
findings from five key pulmonary rehabilitation studies
in bronchiectasis [45-49], recent British Thoracic Society
Guidelines for Pulmonary Rehabilitation recommend re-
ferral to pulmonary rehabilitation for patients with bron-
chiectasis who have breathlessness affecting their activities
of daily living [6]. The most recent of these studies by Lee
et al. [49] recruited patients with a very similar demo-
graphic profile into a quality randomised controlled trial
of eight weeks of pulmonary rehabilitation versus control
and demonstrated that pulmonary rehabilitation was asso-
ciated with short-term improvement in exercise capacity,
dyspnoea and fatigue; although these improvements were
not sustained at 12-month follow-up. The positive effects
of pulmonary rehabilitation on exercise capacity across
chronic respiratory conditions have been shown to con-
sistently diminish over time [6]. With limited access to
maintenance programmes, alternative strategies to reduce
sedentary behaviour and/or increase and sustain physical
activity may be important. Unfortunately, as with earlier
studies, physical activity was not included as an outcome
measure and further research is needed to establish
whether changes in exercise capacity translate to changes
in physical activity or whether physical activity needs to be
specifically targeted in bronchiectasis.
There were important differences in the predictors of
sedentary behaviour versus physical activity. In fact,
decisional balance ‘pros’ score was the only correlate of
sedentary behaviour suggesting that sedentary behaviour
in bronchiectasis could be influenced more by psycho-
logical factors rather than physiological factors. The data
shows that it is important to assess patients’ sedentary
behaviour and physical activity levels directly. We also
propose that it may be important to focus on behaviour
change techniques and other behavioural strategies such
as motivational interviewing [50] rather than exercise
training alone if targeting a decrease in sedentary behav-
iour as well as improved physical activity levels in patients
with bronchiectasis.
Although activity energy expenditure was estimated
using equations developed for healthy populations, an in-
teresting relationship emerged with QOL-B Respiratory
Symptoms scores. Patients with higher activity energy ex-
penditure appeared to have worse respiratory symptoms.
Patients with chronic respiratory disease potentially have
an increased oxygen cost of breathing compared with
healthy populations due to respiratory dynamics [51].
In COPD, recent research suggests that higher physical
activity levels are associated with higher self-efficacy and
less depressive symptoms in patients with COPD [52].
We have shown that patients with bronchiectasis per-
ceived a range of barriers to participation in physical ac-
tivity, with those who were more sedentary perceiving
more barriers. They employed a range of cognitive and
behavioural strategies to modify their physical activity
behaviour. The most employed strategies were: realising
benefits of being physically active, making commitments
to be physically active and replacing inactive choices
with active choices. Future intervention studies could
focus on optimising frequently used strategies as well as
considering the value of less commonly used strategies
to support patients in altering their physical activity
behaviour.
A major strength of this study was the use of validated
instruments to assess physical activity, exercise capacity
and HRQoL in a bronchiectasis population. This facili-
tated rigorous exploration of the correlates of sedentary
behaviour and physical activity in bronchiectasis. One
limitation may be that due to the exploratory nature of
this study, no sample size calculation was performed.
Nevertheless, this exploration has provided a useful
insight into understanding correlates of sedentary behav-
iour and physical activity in bronchiectasis.
Conclusions
In summary, many patients with bronchiectasis demon-
strated a largely inactive lifestyle and few met the recom-
mended physical activity guidelines. FEV1% predicted
and disease severity were not correlates of sedentary
behaviour or physical activity. Exercise capacity was the
strongest correlate of physical activity, and dimensions
of the QOL-B were also important. Despite patients un-
derstanding the benefits of physical activity, many re-
ported low levels of self-confidence in physical activity
in certain situations, particularly when experiencing re-
spiratory symptoms. This study highlights the need for
physical activity interventions in bronchiectasis and pro-
vides information to tailor interventions to this patient
population.
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